Assessing the clinical characteristics and management of COVID-19 among pediatric patients in Ghana : findings and implications

dc.contributor.authorSefah, Israel
dc.contributor.authorSarkodie, Seth Adade
dc.contributor.authorPichierri, Giuseppe
dc.contributor.authorSchellack, Natalie
dc.contributor.authorGodman, Brian
dc.date.accessioned2023-09-27T07:55:02Z
dc.date.available2023-09-27T07:55:02Z
dc.date.issued2023-02
dc.descriptionSUPPLEMENTARY MATERIAL : TABLE S1: Study Questionnaire.en_US
dc.descriptionDATA AVAILABILITY STATEMENT : Additional data are available from the corresponding authors on reasonable request.en_US
dc.description.abstractThere is an increasing focus across countries on researching the management of children admitted to hospital with COVID-19. This stems from an increasing prevalence due to new variants, combined with concerns with the overuse of antimicrobials driving up resistance rates. Standard treatment guidelines (STGs) have been produced in Ghana to improve their care. Consequently, there is a need to document the clinical characteristics of children diagnosed and admitted with COVID-19 to our hospital in Ghana, factors influencing compliance to the STG and treatment outcomes. In all, 201 patients were surveyed between March 2020 and December 2021, with males accounting for 51.7% of surveyed children. Those aged between 6 and 10 years were the largest group (44.8%). Nasal congestion and fever were some of the commonest presenting complaints, while pneumonia was the commonest (80.6%) COVID-19 complication. In all, 80.0% of all admissions were discharged with no untreated complications, with a 10.9% mortality rate. A combination of azithromycin and hydroxychloroquine (41.29%) was the most prescribed antimicrobial regimen. Compliance to the STG was variable (68.2% compliance). Increased compliance was associated with a sore throat as a presenting symptom. Mortality increased following transfer to the ICU. However, current recommendations to prescribe antimicrobials without demonstrable bacterial or fungal infections needs changing to reduce future resistance. These are areas to address in the future.en_US
dc.description.departmentPharmacologyen_US
dc.description.urihttps://www.mdpi.com/journal/antibioticsen_US
dc.identifier.citationSefah, I.A.; Sarkodie, S.A.; Pichierri, G.; Schellack, N.; Godman, B. Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications. Antibiotics 2023, 12, 283. https://doi.org/10.3390/antibiotics12020283.en_US
dc.identifier.issn2079-6382 (print)
dc.identifier.other10.3390/antibiotics12020283
dc.identifier.urihttp://hdl.handle.net/2263/92432
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).en_US
dc.subjectAntimicrobialsen_US
dc.subjectChildrenen_US
dc.subjectGhanaen_US
dc.subjectGuidelinesen_US
dc.subjectHospitalsen_US
dc.subjectOutcomesen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectStandard treatment guidelines (STGs)en_US
dc.titleAssessing the clinical characteristics and management of COVID-19 among pediatric patients in Ghana : findings and implicationsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Sefah_Assessing_2023.pdf
Size:
537.05 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Sefah_AssessingSuppl_2023.pdf
Size:
194.44 KB
Format:
Adobe Portable Document Format
Description:
Supplementary information

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: